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you in the editorial and take the liberty to 
add that any possible cases of alleged mal-
practices should be left to the Medical 
Council to decide about, judiciary coming 
into picture only in the exceptional cir-
cumstances ! 
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Carbamazepine and Electro Convul-
sive Threshold 
The points raised by Sharuia et al, in 
their letter "Does Carbainazepine Alter the 
Electro-Convulsive Threshold" (Joumal,27 
173-174:1985) are topical and interesting. 
1 lowever, the inference ... "Carbamazep-
ine may be interfering with seizure thre-
shold and...therapeutic induction of sei-
zures" seems clouded by the following :-
The patient was getting lithium 1800 
mg., Carbamazepine (CBZ) 800 mg. and 
I'henob.irbitone (PB) 60 mg./day. It is diffi-
cult, especially in an epileptic subject, to in-
criminate CBZ alone out of combination of 
these three drugs which interact with each 
other in a complex manner and influence 
seizure activity. Absctuc or scrum levels of 
PB and CBZ further limits the experimen-
tal design and the scope of extrapolation of 
the data. In addition, animal experiments 
indicate that CBZ suppresses kindling proc-
ess by repetitive sub-threshold electrical 
stimulation of the limbic structures and 
propagation of kindled seizure discharge to 
other brain areas (Wada 1977). On the 
whole, the evidence to date suggests that 
the site of action of CBZ is predominantly 
on the limbic structures rather than the 
midbrain reticular formation or thalamus. 
In the light of these data, and in keeping 
with the pioneering works of Kobayashi 
and co-workers (1967) as quoted by 
Okuma (1983), we feel that... "Carbama-
zepine produces no significant change in 
seizure threshold". This conviction is fur-
ther strengthened by our recent observa-
tion on two patients; while on CBZ alone 
(600-900 mg/day), both could be given 
ECT with usual voltage and duration as in 
those patients not on CBZ. The patients 
reported by the authors might have needed 
more than average duration and stimulus 
due to presence of I'B. It may well be that 
the A-B-A-B design the authors employed 
itself had been responsible for lesser requi-
rement ot stimulus and its duration. The al-
tered schedule of CBZ 400 mg. a.m. and af-
ternoon on the day previous to ECT had 
probably led to a state of relative CBZ 
withdrawal on the next morning when 
ECT was given. This withdrawal accen-
tuated further by PB, could have lowered 
the seizure threshold by producing an al-
tered biological state in a predisposed sub-
ject; this was corrected in the next phase 
when the original t.i.d. schedule was re-
sumed. 
It is not quite understandable 
how... "combined GABA-ergic effect of 
CBZ and ECT" could be held for the obser-
vations reported by the authors. 
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Reply 
Sir, 
The points raised by Dr. Goswami et al 
are only partially correct. We would like to 
clarify that the patient in question was re-
ceiving carbamazepine only for control of 
seizures, and not in combination with phe-
nobarbitone. The other two patients too 
were not on phenobarbitonc. Lithium does 
not alter after discharge threshold and 
seizure severity of hippocampal kindled 
seizures in rats after acute administration, 
and is unlikely to do so after prolonged used 
(Clifford ct al 1985). Kobayashi's state-
ment has already been referred to in our let-
ter, along with a contrary observation. It on-
lv serves to highlight the divergence of 
opinion in the field. 
They go on to suggest regarding the 
state ot "relative CBZ withdrawal". In-
duced seizures have not been studied at va-
rious blood levels, which in any case fluctu-
ate, it would be worthwhile to remember 
that peak CBZ levels occur more than 6 
hours after (range 2-12 hrs), whereas the 
half life is around 20 hrs in those receiving 
it chronically (Kutt 1978). It is not very 
clear yet whether experimental seizures de-
pend upon peak or steady state level, and 
which one ot these the 'relative withdra-
wal' refers to. In any case, it is an interesting 
observation as it illustrates the disparity 
between induced and spontaneous seizures. 
It is not clear how l'B, even it it had been gi-
ven, could have accentuated the withdrawal. 
ECT induces a variety ot effects associat-
ed with ami kindling and anti-con vulsant pro-
perties. It increases benzodiazepine binding, 
and potentiates GABA-ergic and Catechola-
mincrgic mechanism in addition to various 
effects on peptides and hormones (Post et al 
1984). These authors propose these observa-
tions as an explanation for the paradox of an 
anticonvulsant drug and a convulsive treat-
ment being simultaneously efficient in the 
treatment of affective disorder. The mechan-
ism of the anti-epileptic action of GBZ is not 
well understood. GABA-ergic, adenosine re-
ceptor and benzodia7.epine receptor effects 
have all been implicated, as arso in the affec-
tive disorders (Morselli & Lloyd 1985, Post et 
al 1984). We have specifically stated that 
CBZ may interfere with the therapeutic in-
duction of seizures and not the treatment re-
sponse per se. We agree that the site of action 
of CBZ is predominantly on the limbic struc-
tures. 
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